Lactobacillus rhamnosus JL-1 for relieving hypeluricemia as well as metaplasm and application of lactobacillus rhamnosus JL-1

• Main Authors: WANG JUNHAO, MAN CHAOXIN, JIANG YUJUN, WANG CHENCHEN, ZHANG YU, ZHENG MIAO
• Format: Patent
• Language: Chinese; English
• Published: 03.10.2023
• Subjects: BEER; BIOCHEMISTRY; CHEMISTRY; COMPOSITIONS THEREOF; CULTURE MEDIA; ENZYMOLOGY; HUMAN NECESSITIES; HYGIENE; MEDICAL OR VETERINARY SCIENCE; METALLURGY; MICROBIOLOGY; MICROORGANISMS OR ENZYMES; MUTATION OR GENETIC ENGINEERING; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; PROCESSES USING MICROORGANISMS; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS; SPIRITS; VINEGAR; WINE

The invention discloses lactobacillus rhamnosus JL-1 for relieving hyperuricemia as well as a metagen and application of the lactobacillus rhamnosus JL-1, and belongs to the technical field of microorganisms. The lactobacillus rhamnosus JL-1 provided by the invention is preserved in Guangdong Microbial Culture Collection Center on October 9, 2022, and the microbial preservation number is GDMCC NO: 62852; the preservation address is building 59, No.100 courtyard, Xianlie Middle Road, Guangzhou; the lactobacillus rhamnosus strain is characterized in that the lactobacillus rhamnosus strain is classified and named as lactobacillus rhamnosus according to microorganisms. The invention provides the safe and effective application of the lactobacillus rhamnosus JL-1-containing postbiotic composition in the aspect of relieving the hyperuricemia, the serum uric acid content, the urea nitrogen content and the creatinine content of hyperuricemia mice induced by high-purine diet can be reduced, the xanthine oxidase content